Auxly Cannabis Group (XLY) Lytham Partners Spring 2026 Investor Conference summary
Event summary combining transcript, slides, and related documents.
Lytham Partners Spring 2026 Investor Conference summary
28 May, 2026Business overview and market position
Specializes in cultivation and manufacturing of cannabis products, holding a 6.9% Canadian market share and ranking third by market share, with continued growth in 2025 and 2026.
Flagship brand Back Forty is the top cannabis brand in Canada by dollars sold, available in 97% of retail locations, focusing on dried flower, pre-rolls, and vapes.
Strategic partnership with Imperial Brands, which owns 20% of shares, supports international expansion as global markets open.
Achieved adjusted EBITDA profitability for 11 consecutive quarters and net income profitability for eight quarters.
Financial performance and growth
Generated CAD 159 million net revenue, CAD 49 million EBITDA, and CAD 44 million cash flow from operations over the last 12 months.
Maintains 50% gross margin and over 30% EBITDA margin, converting over 90% of EBITDA to cash flow.
Q1 2026 net revenue reached CAD 39.8 million, up 22% year-over-year, with a 55% gross margin and 31% EBITDA margin.
Q1 2026 adjusted EBITDA was CAD 12.3 million, up 65% year-over-year, and cash flow was CAD 11.3 million, up 101%.
Capital allocation focuses on organic growth, select acquisitions, and share repurchases under a normal course issuer bid.
Operational strengths and innovation
Operates Auxly Leamington, a 1.1 million sq ft cultivation facility producing 100,000 kg of dried flower annually, with plans to increase to 150,000 kg.
Facility achieves top-three industry cost profile without sacrificing quality; three of the top 10 selling strains are grown there.
Innovation in dried flower led to the launch of South Point, a premium brand already a top 20 strain in Ontario.
R&D collaboration with a leading tobacco equipment manufacturer enabled advanced pre-roll production; Back Forty dominates pre-rolls and vapes.
SKU efficiency and hardware innovation in vapes, such as the boosted product, drive high-margin growth and incremental sales.
Latest events from Auxly Cannabis Group
- Record Q1 revenue and EBITDA growth, strong cash flow, and new share repurchase program.XLY
Q1 202614 May 2026 - Ranked #3 in Canada, delivering strong growth, profitability, and market-leading cannabis brands.XLY
Investor presentation14 May 2026 - 2025 saw 24% revenue growth, 64% higher Adjusted EBITDA, and strong cash flow conversion.XLY
Q4 202527 Mar 2026 - Delivered 24% revenue growth in 2025 and leads Canadian cannabis with top brands and innovation.XLY
Investor presentation26 Mar 2026 - Q1 2025 saw 29% revenue growth, 48% gross margin, and a return to profitability, but liquidity risks persist.XLY
Q1 202511 Feb 2026 - Record Q2 2025 revenue, profit, and margins, with strong outlook and market leadership.XLY
Q2 202510 Feb 2026 - Net loss narrowed and debt fell, but going concern risk persists amid negative working capital.XLY
Q4 202410 Feb 2026 - Q3 2024 revenue, profit, and market share rose, but liquidity and debt risks persist.XLY
Q3 202410 Feb 2026 - Record Q2 revenue and margin gains, but going concern risks persist.XLY
Q2 202410 Feb 2026